Nautilus Biotechnology, Inc. Earnings Per Share (Diluted)
Nautilus Biotechnology, Inc. (NAUT) reported Earnings Per Share (Diluted) of -$0.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-28
- Nautilus Biotechnology, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.11.
- Nautilus Biotechnology, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.12.
- Nautilus Biotechnology, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.11.
- Nautilus Biotechnology, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.11.
- Nautilus Biotechnology, Inc. earnings per share, diluted for fiscal 2025 was -$0.47.
- Nautilus Biotechnology, Inc. earnings per share, diluted for fiscal 2024 was -$0.56.
- Nautilus Biotechnology, Inc. earnings per share, diluted for fiscal 2023 was -$0.51.
- Nautilus Biotechnology, Inc. earnings per share, diluted for fiscal 2022 was -$0.46.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.11 10-Q · filed 2026-07-28 | -$0.23 10-Q · filed 2026-07-28 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-07-28 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-07-28 |
| 2026-03-31 | -$0.12 10-Q · filed 2026-04-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-07-28 |
| 2025-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-07-28 | -$0.47 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.11 10-Q · filed 2025-10-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-07-28 | -$0.36 10-Q · filed 2025-10-28 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-07-28 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-07-28 | -$0.25 10-Q · filed 2026-07-28 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-07-28 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-07-28 |
| 2025-03-31 | -$0.13 10-Q · filed 2026-04-28 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.56 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.13 10-Q · filed 2025-10-28 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-10-28 | -$0.42 10-Q · filed 2025-10-28 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-10-28 |
| 2024-06-30 | -$0.14 10-Q · filed 2025-07-31 | -$0.29 10-Q · filed 2025-07-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-07-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-07-31 |
| 2024-03-31 | -$0.15 10-Q · filed 2025-04-29 | -$0.29 derived: net income ÷ weighted average shares · filed 2025-04-29 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-04-29 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-04-29 |
| 2023-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.51 10-K · filed 2025-02-27 |
| 2023-09-30 | -$0.13 10-Q · filed 2024-10-29 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-10-29 | -$0.37 10-Q · filed 2024-10-29 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-10-29 |
| 2023-06-30 | -$0.13 10-Q · filed 2024-07-30 | -$0.25 10-Q · filed 2024-07-30 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-07-30 |
| 2023-03-31 | -$0.12 10-Q · filed 2024-04-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-04-30 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-04-30 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-04-30 |
| 2022-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.46 10-K · filed 2024-02-28 |
| 2022-09-30 | -$0.11 10-Q · filed 2023-10-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-10-31 | -$0.36 10-Q · filed 2023-10-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-10-31 |
| 2022-06-30 | -$0.12 10-Q · filed 2023-08-02 | -$0.24 10-Q · filed 2023-08-02 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-08-02 | -$0.50 derived: net income ÷ weighted average shares · filed 2023-08-02 |
| 2022-03-31 | -$0.13 10-Q · filed 2023-05-02 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-05-02 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-05-02 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-05-02 |
| 2021-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.25 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.60 10-K · filed 2023-02-23 |
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-01 | -$0.28 derived: net income ÷ weighted average shares · filed 2022-11-01 | -$0.47 10-Q · filed 2022-11-01 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-11-01 |
| 2021-06-30 | -$0.19 10-Q · filed 2022-08-02 | -$0.43 10-Q · filed 2022-08-02 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-08-02 | -$0.76 derived: net income ÷ weighted average shares · filed 2022-08-02 |
| 2021-03-31 | -$0.25 10-Q · filed 2022-05-03 | -$0.43 derived: net income ÷ weighted average shares · filed 2022-05-03 | -$0.56 derived: net income ÷ weighted average shares · filed 2022-05-03 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-05-03 |
| 2020-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.54 10-K · filed 2022-02-24 |
| 2020-09-30 | -$0.13 10-Q · filed 2021-11-02 | -$0.25 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$0.36 10-Q · filed 2021-11-02 | |
| 2020-06-30 | -$0.12 10-Q · filed 2021-08-10 | -$0.23 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |